VolitionRx Limited Proceeds from Notes Payable
VolitionRx Limited (VNRX) reported Proceeds from Notes Payable of $0 for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2023-11-14
- VolitionRx Limited proceeds from notes payable for the quarter ending 2017-12-31 was $293.90K.
- VolitionRx Limited proceeds from notes payable for the quarter ending 2017-09-30 was $243.50K.
- VolitionRx Limited proceeds from notes payable for the quarter ending 2017-06-30 was $376.93K.
- VolitionRx Limited proceeds from notes payable for the quarter ending 2017-03-31 was $287.65K.
- VolitionRx Limited proceeds from notes payable for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- VolitionRx Limited proceeds from notes payable for fiscal 2020 was $584.45K.
- VolitionRx Limited proceeds from notes payable for fiscal 2017 was $1.20M, a 153.17% increase from fiscal 2016.
- VolitionRx Limited proceeds from notes payable for fiscal 2016 was $474.77K.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 5 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month | Proceeds from Notes Payable 17 month | Proceeds from Notes Payable 20 month | Proceeds from Notes Payable 23 month | Proceeds from Notes Payable 26 month | Proceeds from Notes Payable 29 month | Proceeds from Notes Payable 32 month | Proceeds from Notes Payable 35 month | Proceeds from Notes Payable 38 month | Proceeds from Notes Payable 41 month | Proceeds from Notes Payable 44 month | Proceeds from Notes Payable 47 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 | |||||||||||||||
| 2022-09-30 | $210.60K 10-Q · filed 2023-11-14 | |||||||||||||||
| 2021-12-31 | $0.00 10-K · filed 2022-03-30 | |||||||||||||||
| 2020-12-31 | $584.45K 10-K · filed 2022-03-30 | |||||||||||||||
| 2018-06-30 | $875.65K 10-Q · filed 2018-08-13 | |||||||||||||||
| 2017-12-31 | $293.90K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $537.41K derived: sum of 2 quarters · filed 2018-03-01 | $914.33K derived: sum of 3 quarters · filed 2018-08-13 | $1.20M 10-K · filed 2018-03-01 | ||||||||||||
| 2017-09-30 | $243.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $620.43K derived: sum of 2 quarters · filed 2018-08-13 | $908.08K 10-Q · filed 2017-11-09 | |||||||||||||
| 2017-06-30 | $376.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $664.57K 10-Q · filed 2018-08-13 | ||||||||||||||
| 2017-03-31 | $287.65K 10-Q · filed 2018-05-10 | |||||||||||||||
| 2016-12-31 | $474.77K 10-K · filed 2018-03-01 | |||||||||||||||
| 2014-06-30 | $59.94K 10-Q · filed 2014-08-01 | |||||||||||||||
| 2014-03-31 | $59.94K 10-Q · filed 2014-05-15 | |||||||||||||||
| 2013-12-31 | $59.94K 10-K · filed 2014-03-28 | |||||||||||||||
| 2013-09-30 | $59.94K 10-Q · filed 2013-10-31 | |||||||||||||||
| 2013-06-30 | $59.94K 10-Q · filed 2013-07-29 | |||||||||||||||
| 2013-03-31 | $59.94K 10-Q · filed 2013-05-06 | |||||||||||||||
| 2012-12-31 | $59.94K 10-K · filed 2013-04-01 | |||||||||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $0.00 derived: sum of 2 quarters · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | $0.00 derived: sum of 4 quarters · filed 2012-11-14 | $59.94K 10-Q · filed 2012-11-14 | |||||||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $0.00 10-Q · filed 2012-08-14 | $0.00 derived: sum of 3 quarters · filed 2012-08-14 | $0.00 derived: sum of 4 quarters · filed 2012-11-14 | $59.94K 10-Q · filed 2012-08-14 | |||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2012-05-15 | $0.00 derived: sum of 2 quarters · filed 2012-05-15 | $0.00 derived: sum of 3 quarters · filed 2012-11-14 | $0.00 derived: sum of 4 quarters · filed 2012-11-14 | $59.94K 10-Q · filed 2012-05-15 | |||||||||||
| 2011-12-31 | $0.00 derived: 10-KT/A 12 month − 10-Q 9 month · filed 2012-05-08 | $0.00 derived: sum of 2 quarters · filed 2012-11-14 | $0.00 derived: sum of 3 quarters · filed 2012-11-14 | $0.00 10-KT/A · filed 2012-05-08 | $59.94K 10-KT/A · filed 2012-05-08 | |||||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $0.00 derived: sum of 2 quarters · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | |||||||||||||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $0.00 10-Q · filed 2012-08-14 | ||||||||||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-15 | |||||||||||||||
| 2010-12-31 | $59.94K 10-KT/A · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |